EYE » Topics » Cataract/Implant sales rose 4.3 percent to $140.2 million.
This excerpt taken from the EYE 8-K filed Aug 2, 2007.
Cataract/Implant sales rose 4.3 percent to $140.2 million.
Total intraocular lens (IOL) sales rose 8.0 percent to $81.3 million.
Monofocal IOL sales rose 5.4 percent to $66.8 million, reflecting continued strong growth of the Tecnis® IOL franchise.
Refractive IOL sales grew 21.8 percent to $14.5 million, reflecting continued demand for the companys ReZoom®, Tecnis® Multifocal, VerisyseTM and
VeriflexTM IOLs. Compared to the first-quarter of 2007, refractive IOL sales rose 12.6 percent, demonstrating continued market share gains.
AMOs Healon® family of viscoleastics grew 0.5 percent.
Total viscoelastics sales of $32.3 million declined 1.6 percent.
Phacoemulsification sales declined 2.2 percent to $21.7 million, due primarily to anticipated lower equipment sales
ahead of the commercial release of the new WhiteStar SignatureTM phacoemulsification system in the third quarter. Surgical pack sales rose 6.4 percent.
Bet you've never seen portfolio analytics like these.